Gongfu Zhou Selected Research

itacitinib

1/2022	A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies.
1/2021	Effect of Hepatic Impairment on the Pharmacokinetics of Itacitinib.
1/2020	The Effect of Renal Impairment on the Pharmacokinetics and Safety of Itacitinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gongfu Zhou Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 06/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Multiple Myeloma 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 11/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020
1	Autoimmune Diseases of the Nervous System 10/2020
1	Hypotension (Low Blood Pressure) 10/2020
1	Dehydration (Water Stress) 10/2020
1	Hyponatremia 10/2020
1	Fatigue 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Nausea 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Polycythemia Vera 11/2016
1	Primary Myelofibrosis (Myelosclerosis) 11/2016
1	Endometrial Neoplasms (Endometrial Cancer) 07/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2014
1	Osteomyelitis 05/2014
1	Osteonecrosis (Kienbock's Disease) 05/2014
1	Carcinoma (Carcinomatosis) 05/2014
1	Rectal Neoplasms (Rectal Cancer) 08/2013
1	Wound Infection (Wound Infections) 08/2013
1	Intestinal Perforation 06/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Necrotizing Enterocolitis 02/2009
1	Patent Ductus Arteriosus 02/2009
1	Bronchopulmonary Dysplasia 02/2009
1	Body Weight (Weight, Body) 02/2009
1	Chorioamnionitis 02/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2009

Drug/Important Bio-Agent (IBA)

3	itacitinibIBA 01/2022 - 01/2020
2	epacadostatIBA 01/2023 - 10/2020
2	Janus Kinase 1IBA 01/2022 - 01/2020
1	durvalumabIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Janus KinasesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	parsaclisibIBA 11/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2020
1	atezolizumabIBA 10/2020
1	INCB054329IBA 01/2020
1	INCB057643IBA 01/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	Oxygen (Dioxygen)IBA 02/2009
1	SteroidsIBA 02/2009

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 07/2015 - 08/2013
1	Renal Dialysis (Hemodialysis) 01/2020
1	Pancreaticoduodenectomy 05/2015
1	Radiotherapy 05/2014
1	Length of Stay 08/2013
1	Conservative Treatment 06/2013